| NCT Number | NCT07442006 |
| Lead Sponsor | JW Pharmaceutical |
| Conditions | Type 2 Diabetes Mellitus (T2DM) |
| Enrollment | 178 participants |
| Start Date | 2025-10-29 |
| Primary Completion | 2027-03-31 (estimated) |
| Study Completion | 2027-03-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-02 |